US · CCEP · BEVERAGES - NON-ALCOHOLIC
Coca-Cola Europacific Partners PLC (CCEP) intrinsic value and stock valuation
$115.53as of 2026-11-21 · Mkt cap 48B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Coca-Cola Europacific Partners PLC DCF and intrinsic value
InvestorsCraft values CCEP with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from CCEP’s statements →
Coca-Cola Europacific Partners PLC Graham Number
Graham Number: $41.77d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Target Corporation (TGT) $165.98
- Ambev S.A. (ABEV) $2.61
- Keurig Dr Pepper Inc. (KDP) $34.84
- Sysco Corporation (SYY) $78.17
- The Hershey Company (HSY) $175.48
- Kenvue Inc. (KVUE) $19.31
- Kimberly-Clark Corporation (KMB) $106.38
- The Kroger Co. (KR) $68.44
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $20.9B | $20.4B | $18.3B | $17.3B | $13.8B |
| Operating income | $2.79B | $2.13B | $2.34B | $2.09B | $1.52B |
| Net income | $1.94B | $1.42B | $1.67B | $1.51B | $982M |
| EPSd | $4.26M | $3.08M | $3.64M | $3.29M | $2.15M |
| Operating cash flow | $2.95B | $3.06B | $2.81B | $2.93B | $2.12B |
| Capital expenditure | -$-750M | -$-791M | -$-672M | -$-603M | -$-349M |
| Free cash flow | $2.2B | $2.27B | $2.13B | $2.33B | $1.77B |
| Total assets | $29.9B | $31.1B | $29.3B | $29.3B | $29.1B |
| Total debt | $10.7B | $11.3B | $11.4B | $11.9B | $13.1B |
| Net debt | $9.78B | $9.77B | $9.98B | $10.5B | $11.7B |
| Total equity | $8.3B | $8.99B | $7.98B | $7.45B | $7.21B |
| Cash and short-term investments | $972M | $1.71B | $1.99B | $1.64B | $1.47B |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $20.9B | $20.4B | $18.3B | $17.3B | $13.8B |
| Cost of revenue | $13.5B | $13.2B | $11.6B | $11.1B | $8.66B |
| Gross profit | $7.44B | $7.28B | $6.73B | $6.24B | $5.1B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $4.65B | $4.68B | $4.39B | $4.09B | $3.39B |
| Other expenses | -$-5M | $475M | -$-1M | $70M | $202M |
| Operating expenses | $4.64B | $5.15B | $4.39B | $4.16B | $3.59B |
| Cost and expenses | $18.1B | $18.3B | $16B | $15.2B | $12.2B |
| Interest income | $98.9M | $55M | $114M | $17M | $44.8M |
| Interest expense | $293.9M | $242M | $162M | $131M | $95.9M |
| Depreciation and amortization | $637M | $633M | $781M | $772M | $722M |
| Ebitda | $3.43B | $3.24B | $3.23B | $2.93B | $2.44B |
| Operating income | $2.79B | $2.13B | $2.34B | $2.09B | $1.52B |
| Total other income/expenses, net | -$-224M | -$-196M | -$-136M | -$-129M | -$-134M |
| Income before tax | $2.57B | $1.94B | $2.2B | $1.96B | $1.38B |
| Income tax expense | $590M | $492M | $534M | $436M | $394M |
| Net income | $1.94B | $1.42B | $1.67B | $1.51B | $982M |
| Weighted average shares outstanding | $456M | $460.4M | $459M | $457M | $456M |
| Weighted average diluted shares outstanding | $456M | $461M | $459M | $458M | $457M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $972M | $1.71B | $1.99B | $1.64B | $1.47B |
| Net receivables | $2.78B | $2.87B | $2.85B | $2.77B | $2.6B |
| Inventory | $1.55B | $1.61B | $1.36B | $1.38B | $1.16B |
| Total current assets | $6.08B | $6.64B | $6.61B | $6.54B | $5.76B |
| Property, plant and equipment, net | $6.16B | $6.43B | $5.34B | $5.2B | $5.25B |
| Goodwill and intangible assets | $17B | $17.4B | $16.9B | $17.1B | $17.3B |
| Long-term investments | $80M | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current assets | $23.8B | $24.5B | $22.6B | $22.8B | $23.3B |
| Total assets | $29.9B | $31.1B | $29.3B | $29.3B | $29.1B |
| Accounts payable | $3.03B | $2.67B | $2.31B | $2.22B | $1.69B |
| Short-term debt | $470M | $1.39B | $1.3B | $1.34B | $1.35B |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $7.59B | $8.15B | $7.28B | $7.31B | $6.09B |
| Long-term debt | $10.2B | $9.94B | $10.1B | $10.6B | $11.8B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $14B | $14B | $14B | $14.6B | $15.8B |
| Capital lease obligations | $699M | $708M | $692M | $676M | $643M |
| Total liabilities | $21.6B | $22.1B | $21.3B | $21.9B | $21.9B |
| Common stock | $5M | $5M | $5M | $5M | $5M |
| Retained earnings | $8.82B | $8.8B | $8.23B | $7.43B | $6.68B |
| Accumulated other comprehensive income (loss) | -$-1.3B | -$-625M | -$-536M | -$-220M | $131M |
| Total equity | $8.3B | $8.99B | $7.98B | $7.45B | $7.21B |
| Total investments | $134M | $150M | $568M | $256M | $58M |
| Total debt | $10.7B | $11.3B | $11.4B | $11.9B | $13.1B |
| Net debt | $9.78B | $9.77B | $9.98B | $10.5B | $11.7B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $2.57B | $1.42B | $1.67B | $1.96B | $982M |
| Depreciation and amortization | $923M | $933M | $792M | $816M | $722M |
| Stock-based compensation | $47M | $45M | $57M | $33M | $16M |
| Change in working capital | -$-165.21M | $174M | $232M | $427M | $114M |
| Accounts receivable | -$-218.04M | $37M | -$-5M | -$-282M | -$-242M |
| Inventory | -$-15.37M | -$-37M | $6M | -$-244M | -$-1M |
| Accounts payable | $536.9M | $170.9M | $121.5M | $869.1M | $527.2M |
| Net cash provided by operating activities | $2.95B | $3.06B | $2.81B | $2.93B | $2.12B |
| Investments in property, plant and equipment | -$-912.51M | -$-791M | -$-672M | -$-603M | -$-349M |
| Acquisitions, net | $161.4M | -$-1.52B | -$-5M | $11M | -$-5.4B |
| Net cash used for investing activities | -$-632M | -$-1.96B | -$-937M | -$-645M | -$-5.61B |
| Common stock issued | $960K | $31M | $43M | $13M | $28M |
| Common stock repurchased | -$-1B | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | -$-890.41M | -$-910M | -$-841M | -$-763M | -$-638M |
| Net cash used for financing activities | -$-2.89B | -$-973M | -$-1.82B | -$-2.28B | $3.29B |
| Net change in cash | -$-645M | $144M | $32M | -$-20M | -$-116M |
| Cash at end of period | $917.6M | $1.56B | $1.42B | $1.39B | $1.41B |
| Operating cash flow | $2.95B | $3.06B | $2.81B | $2.93B | $2.12B |
| Capital expenditure | -$-750M | -$-791M | -$-672M | -$-603M | -$-349M |
| Free cash flow | $2.2B | $2.27B | $2.13B | $2.33B | $1.77B |
Line items
Line items
Line items
About Coca-Cola Europacific Partners PLC
Coca-Cola Europacific Partners PLC (CCEP), along with its affiliated entities, focuses on the creation, distribution, and sale of a wide array of non-alcoholic, ready-to-consume beverages. Their diverse product portfolio includes sparkling drinks, still and enhanced water products, isotonic options, teas, coffees, juices, as well as a variety of energy drinks and mixers. These offerings are marketed under numerous prominent brands, notably flagship names such as Coca-Cola, Fanta, Sprite, and Monster Energy, among a host of others. In addition to its primary beverage business, CCEP also oversees bottling operations and other related activities. As of March 15, 2022, the company served an estimated 600 million consumers. Founded in 1986, the firm maintains its headquarters in Uxbridge, United Kingdom. It officially rebranded as Coca-Cola Europacific Partners PLC in May 2021, having previously operated under the name Coca-Cola European Partners plc.
- CEO
- Damian Paul Gammell
- Employees
- 39K
- Beta
- 0.49
Explore
Frequently asked questions
What is the intrinsic value of Coca-Cola Europacific Partners PLC (CCEP)?
Coca-Cola Europacific Partners PLC (CCEP) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is CCEP undervalued?
CCEP trades at a price of $115.53 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.